Spinocerebellar ataxia Clinical Trials

2 recruiting

Spinocerebellar ataxia Trials at a Glance

12 actively recruiting trials for spinocerebellar ataxia are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Paris, Angers, and Tübingen. Lead sponsors running spinocerebellar ataxia studies include Assistance Publique - Hôpitaux de Paris, Chang Gung University, and The University of Melbourne.

Browse spinocerebellar ataxia trials by phase

Treatments under study

About Spinocerebellar ataxia Clinical Trials

Looking for clinical trials for Spinocerebellar ataxia? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Spinocerebellar ataxia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Spinocerebellar ataxia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)

Spinocerebellar Ataxia Type 27B
University Hospital Tuebingen300 enrolled5 locationsNCT06472557
Recruiting
Not Applicable

Deep Brain Stimulation for Spinocerebellar Ataxia

Spinocerebellar Ataxia Type 6Spinocerebellar Ataxia (SCA)
University of California, San Francisco5 enrolled2 locationsNCT07288437
Recruiting
Phase 1

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Spinocerebellar Ataxia Type 2
Arrowhead Pharmaceuticals36 enrolled16 locationsNCT06672445
Recruiting
Not Applicable

Autosomal Dominant Spinocerebellar Ataxias and Social Cognition

Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)
University Hospital, Angers160 enrolled1 locationNCT07099651
Recruiting
Phase 3

A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene

Spinocerebellar Ataxia 27B (SCA27B)
Assistance Publique - Hôpitaux de Paris70 enrolled9 locationsNCT07185347
Recruiting
Phase 1Phase 2

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease
Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+188 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Not Applicable

Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity

Spinocerebellar Ataxias
Chang Gung University40 enrolled1 locationNCT06600269
Recruiting
Not Applicable

Electrical Stimulation Cycling Training Effects on SCA

Spinocerebellar Ataxia (SCA)
Chang Gung University145 enrolled1 locationNCT06363058
Recruiting

Biomarker Research in Inherited Movement Disorders

Spinocerebellar AtaxiasInherited Movement DisordersHyperkinetic Disorders
Assistance Publique - Hôpitaux de Paris4,000 enrolled1 locationNCT05034172
Recruiting

SpeechATAX: Intensive home based biofeedback driven speech treatment for hereditary ataxia

DysarthriaSpinocerebellar ataxia
The University of Melbourne100 enrolled6 locationsACTRN12618000519257
Recruiting

Speech treatment for spinocerebellar ataxia and Friedreich ataxia

DysarthriaSpinocerebellar ataxia
The University of Melbourne30 enrolled3 locationsACTRN12616001582448